Meningitis News and Research

Latest Meningitis News and Research

Scientists, WHO warn of public health implications of proposed mercury ban due to its use in vaccines

"Scientists are warning officials negotiating a global treaty on mercury that banning the deadly chemical completely would be dangerous for public health because of the chemical's use in vaccines," the Associated Press reports.

24 Oct 2011

Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA

Pfizer Inc. announced today that additional data from several clinical studies of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) conducted in adults 50 years and older will be presented during the 49th Annual Meeting of the Infectious Diseases Society of America, which is being held Oct. 20-23, 2011, in Boston, Mass.

22 Oct 2011

Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show

"Treating tuberculosis (TB) and HIV infections at the same time can be a challenge for patients and their doctors, but attacking both diseases early and aggressively isn't harmful and could save the lives of those who are sickest," according to a global study led by researchers from the University of California, San Francisco (UCSF) and published Wednesday in the New England Journal of Medicine (NEJM), the San Francisco Chronicle reports.

21 Oct 2011

RTS,S vaccine reduces risk of severe malaria in African children

First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.

19 Oct 2011

First results from phase 3 malaria vaccine candidate trial

18 Oct 2011

VEC and AMA release updated information guide, 'Vaccines and Teens'

This week at the annual meeting of the American Academy of Pediatrics, the Vaccine Education Center at The Children's Hospital of Philadelphia (VEC) and the American Medical Association released an updated information guide called Vaccines and Teens for parents and physicians, detailing the most current recommendations and information about critical immunizations for older children.

18 Oct 2011

Specific MIF gene variant plays a crucial role against bacterial infections

Why are some people prone to severe infections, while others handle them with less difficulty? A new research report appearing online in the FASEB Journal (http://www.fasebj.org) attempts to answer this question by shedding light on the genetic differences that influence our ability to fight off bacterial infections.

13 Oct 2011

Belfast Health, Social Care Trust license new meningitis test to HiberGene

Belfast Health and Social Care Trust has licensed its novel rapid meningitis diagnostic test to HiberGene Diagnostics Ltd, an Irish start-up client company of NovaUCD, the Innovation and Technology Transfer Centre at University College Dublin.

7 Oct 2011

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Pfizer Inc. today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis, a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.

1 Oct 2011

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.

28 Sep 2011

Researchers discover how a novel type of antibody works against pneumococcal bacteria

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a novel type of antibody works against pneumococcal bacteria.

23 Sep 2011

ASU scientists receive USDA grants to combat food-related illness

Roughly 1 in six Americans are sickened every year by food-borne ailments, according to the Centers for Disease Control and Prevention. The effects of these illnesses range from acutely unpleasant to lethal, and the problem may be getting worse, as our food supply becomes more global, with an increasing number of antibiotic-resistant pathogens.

21 Sep 2011

Supplement in USA Today highlights global NTD eradication efforts

This supplement (.pdf) by Mediaplanet, distributed in the September 15 issue of USA Today in select cities nationwide, examines the latest programs dedicated to eradicating neglected tropical diseases (NTDs) worldwide.

17 Sep 2011

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1 clinical study of VT-1161, an oral, potent and selective antifungal agent. VT-1161 is a novel small molecule discovered by Viamet Pharmaceuticals using its proprietary Metallophile Technology.

14 Sep 2011

Eleven UvA researchers named as recipients of ERC Starting Grants

Eleven researchers from the University of Amsterdam (UvA) have been named as recipients of Starting Independent Researcher Grants from the European Research Council.

31 Aug 2011

High risk of serious complications or death in children with SP-HUS

Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.

30 Aug 2011

IOM report: Few health problems are clearly associated with vaccines

An analysis of more than 1,000 research articles concluded that few health problems are caused by or clearly associated with vaccines.

26 Aug 2011

IMMY, University of Nevada receive FDA clearance for CrAg Lateral Flow Assay

The Food and Drug Administration has cleared a new diagnostic test that will help save the lives of hundreds of thousands of AIDS patients stricken with cryptococcosis, a fungal meningitis.

25 Aug 2011

Emory team identifies conditions that make memory T cells slip away during chronic infections

After recovering from the flu or another acute infection, your immune system is ready to react quickly if you run into the same virus again. White blood cells called memory T cells develop during the infection and help the immune system remember the virus and attack it if it comes back.

19 Aug 2011

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has completed patient recruitment in a clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.

17 Aug 2011

Meningitis News and Research

Latest Meningitis News and Research

Scientists, WHO warn of public health implications of proposed mercury ban due to its use in vaccines

Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA

Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show

RTS,S vaccine reduces risk of severe malaria in African children

First results from phase 3 malaria vaccine candidate trial

VEC and AMA release updated information guide, 'Vaccines and Teens'

Specific MIF gene variant plays a crucial role against bacterial infections

Belfast Health, Social Care Trust license new meningitis test to HiberGene

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

Researchers discover how a novel type of antibody works against pneumococcal bacteria

ASU scientists receive USDA grants to combat food-related illness

Supplement in USA Today highlights global NTD eradication efforts

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Eleven UvA researchers named as recipients of ERC Starting Grants

High risk of serious complications or death in children with SP-HUS

IOM report: Few health problems are clearly associated with vaccines

IMMY, University of Nevada receive FDA clearance for CrAg Lateral Flow Assay

Emory team identifies conditions that make memory T cells slip away during chronic infections

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Meningitis News and Research

Latest Meningitis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in